🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Content Elimination

Based on TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.

After minutes of entering one community, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Pricing

Inside these communities, messages display black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially serious medical dangers”.